Cellworks
Cellworks logo

Cellworks

Personalized cancer therapy.

About

Founded

2005

Headquarters

South San Francisco, California

Industry

Biotech

Company Description

Cellworks is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients and patient cohorts using a breakthrough Computational Biology Model (CBM) and biosimulation technology. Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers and software technologists working toward a common goal – attacking serious diseases to improve the lives of patients.

Quick Links

WebsiteJobs

Funding

Total Raised

$33 million

Valuation

Undisclosed

Significant Investors

Sequoia Capital, Artiman, UnitedHealth Group, Agilent

Company Traction

  • Cellworks Computational Omics Biology Model has a network of 7,000+ human genes, 30,000+ molecular species, and 100+ signaling pathways.
  • In 2022, Cellworks won The Challengers Innovative Business of the Year Award by Dell Technologies.

Leadership Team

  • Yatin Mundkur: CEO at Cellworks.
  • Michele Macpherson: Chief Business Officer & CFO at Cellworks. Former COO & CFO at Pinpoint Predictive.
  • Ansu Kumar: Chief Scientific Officer at Cellworks. Former Associate Manager R&D at Cellworks.
  • Drew Watson: Chief Biostatistician and Clinical Studies at Cellworks. Former Biostatistics & Clinical Studies at Invitae.

Press

People also viewed